A 56-day Clinical Study on Facial Skin Rejuvenation

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 18, 2023

Primary Completion Date

January 27, 2024

Study Completion Date

August 15, 2024

Conditions
Skin ManifestationsWrinklePhotoaging
Interventions
COMBINATION_PRODUCT

Fractional picosecond laser treatment followed by daily use of formulations containing MLYAAT-1002®.

Each subject will receive a single treatment of the fractional picosecond laser, followed by the first application of the active comparator on the randomly assigned side of the split-face (the treatment side) on the same day, and sequently, will apply the active comparator to this side twice a day for 56 days.

COMBINATION_PRODUCT

Fractional picosecond laser treatment followed by daily use of formulations without MLYAAT-1002®

Each subject will receive a single treatment of the fractional picosecond laser, followed by the first application of the placebo comparator on the randomly assigned side of the split-face (the control side) on the same day, and sequently, will apply the placebo comparator to this side twice a day for 56 days.

Trial Locations (1)

200072

Shanghai China-norm Quality Technical Service Co ,Ltd, Shanghai

All Listed Sponsors
lead

Botanee Group Co., Ltd.

INDUSTRY

NCT06188338 - A 56-day Clinical Study on Facial Skin Rejuvenation | Biotech Hunter | Biotech Hunter